
First Patient Enrolled in Phase 3 Recurrent Prostate Cancer Trial
The first patient has been enrolled in the phase 3 PROSTATE-IQ clinical trial being conducted in men with prostate cancer recurrence following a prostatectomy, according to a news release published by Artera. The clinical trial is utilizing the ArteraAI …